文章摘要
郭 瑞,黄漫清,崔 颖,陈 景,郑子仁.糖尿病视网膜病变患者血清hs-CRP、CHIT1、midkine与病变严重程度和视力残疾的关系[J].,2024,(17):3233-3236
糖尿病视网膜病变患者血清hs-CRP、CHIT1、midkine与病变严重程度和视力残疾的关系
Relationship between Serum hs-CRP, CHIT1, midkine and Severity of the Disease and Visual Disability in Patients with Diabetic Retinopathy
投稿时间:2024-04-08  修订日期:2024-04-30
DOI:10.13241/j.cnki.pmb.2024.17.006
中文关键词: 视力残疾  糖尿病视网膜病变  hs-CRP  CHIT1  midkine  病变严重程度
英文关键词: Visual disability  Diabetic retinopathy  hs-CRP  CHIT1  Midkine  Severity of the disease
基金项目:广东省医学科学技术研究基金项目(A2016202)
作者单位E-mail
郭 瑞 南方医科大学附属广东省人民医院(广东省医学科学院)眼科 广东 广州 510080 13922331056@163.com 
黄漫清 南方医科大学附属广东省人民医院(广东省医学科学院)眼科 广东 广州 510080  
崔 颖 南方医科大学附属广东省人民医院(广东省医学科学院)眼科 广东 广州 510080  
陈 景 南方医科大学附属广东省人民医院(广东省医学科学院)眼科 广东 广州 510080  
郑子仁 南方医科大学附属广东省人民医院(广东省医学科学院)眼科 广东 广州 510080  
摘要点击次数: 174
全文下载次数: 89
中文摘要:
      摘要 目的:探讨糖尿病视网膜病变(DR)患者血清超敏C反应蛋白(hs-CRP)、几丁质酶1(CHIT1)、中期因子(midkine)与病变严重程度和视力残疾的关系。方法:选取2021年3月-2022年12月期间我院收治的198例2型糖尿病DR患者,根据病变严重程度,分为非增生型DR、增生型DR,例数分别为121例、77例,对比非增生型DR和增生型DR血清hs-CRP、CHIT1、midkine水平。以门诊复查的随访形式随访1年,根据DR患者视力残疾发生情况将患者分为视力残疾组和非视力残疾组,例数分别为31例和167例,对比视力残疾组和非视力残疾组的血清hs-CRP、CHIT1、midkine水平,采用Logistic回归分析视力残疾的危险因素。结果:增生型DR患者血清hs-CRP、CHIT1、midkine水平高于非增生型DR患者(P<0.05)。视力残疾组的血清hs-CRP、CHIT1、midkine水平高于非视力残疾组(P<0.05)。单因素分析结果显示:DR患者视力残疾与性别、年龄、眼压、空腹血糖(FPG)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、胰岛素抵抗指数(HOMA-IR)无关(P>0.05),与糖尿病病程、DR病程、糖化血红蛋白(HbAlc)有关(P<0.05)。Logistic回归分析显示:糖尿病病程越长、DR病程越长、hs-CRP升高、CHIT1升高、midkine升高是DR患者视力残疾的主要危险因素(P<0.05)。结论:DR患者血清hs-CRP、CHIT1、midkine升高,与病变严重程度有关,同时DR患者视力残疾受到hs-CRP、CHIT1、midkine的影响,值得引起临床重视。
英文摘要:
      ABSTRACT Objective: To investigate the relationship between serum high-sensitivity C-reactive protein (hs-CRP), chitinase 1 (CHIT1), mid-term factor (midkine) and severity of the disease and visual disability in patients with diabetic retinopathy (DR). Methods: 198 type 2 DR patients admitted to our hospital from March 2021 to December 2022 were selected, according to the severity of the disease, patients were divided into non-proliferative DR and proliferative DR, the number of cases was 121 and 77 cases respectively, the levels of serum hs-CRP, CHIT1 and midkine in non-proliferative DR and proliferative DR were compared. The patients were followed up for 1 year in the form of outpatient review to observe the occurrence of visual disability in DR patients. The patients were divided into visual disability group and non-visual disability group, the number of cases was 31 cases and 167 cases respectively. The levels of serum hs-CRP, CHIT1 and midkine in visual disability group and non-visual disability group were compared, the risk factors of visual disability were analyzed by Logistic regression. Results: The levels of serum hs-CRP, CHIT1 and midkine in patients with proliferative DR were higher than those in patients with non-proliferative DR (P<0.05). The levels of serum hs-CRP, CHIT1 and midkine in visual disability group were higher than those in non-visual disability group (P<0.05). The results of univariate analysis showed that, visual disability in DR patients was not related to gender, age, intraocular pressure, fasting blood glucose (FPG), triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and insulin resistance index (HOMA-IR) (P>0.05), but related to the course of diabetes, the course of DR and glycosylated hemoglobin (HbAlc) (P<0.05). Logistic regression analysis showed that, the longer the course of diabetes, the longer the course of DR, the higher hs-CRP, the higher CHIT1 and the higher midkine were the main risk factors for visual disability in DR patients (P<0.05). Conclusion: The increase of serum hs-CRP, CHIT1 and midkine in DR patients are relate to the severity of the disease, and the visual disability of DR patients is affected by hs-CRP, CHIT1 and midkine, which is worthy of clinical attention.
查看全文   查看/发表评论  下载PDF阅读器
关闭